Schrodinger Operating Margin 2019-2025 | SDGR
Current and historical operating margin for Schrodinger (SDGR) over the last 10 years. The current operating profit margin for Schrodinger as of June 30, 2025 is -76.22%.
| Schrodinger Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $0.24B | $-0.19B | -81.09% |
| 2025-03-31 | $0.23B | $-0.19B | -83.91% |
| 2024-12-31 | $0.21B | $-0.21B | -100.97% |
| 2024-09-30 | $0.19B | $-0.22B | -112.95% |
| 2024-06-30 | $0.20B | $-0.21B | -102.49% |
| 2024-03-31 | $0.19B | $-0.21B | -113.23% |
| 2023-12-31 | $0.22B | $-0.18B | -82.03% |
| 2023-09-30 | $0.20B | $-0.18B | -88.50% |
| 2023-06-30 | $0.19B | $-0.17B | -86.08% |
| 2023-03-31 | $0.20B | $-0.15B | -75.63% |
| 2022-12-31 | $0.18B | $-0.15B | -81.22% |
| 2022-09-30 | $0.17B | $-0.14B | -82.94% |
| 2022-06-30 | $0.16B | $-0.13B | -79.75% |
| 2022-03-31 | $0.16B | $-0.12B | -75.48% |
| 2021-12-31 | $0.14B | $-0.11B | -81.16% |
| 2021-09-30 | $0.13B | $-0.11B | -84.80% |
| 2021-06-30 | $0.12B | $-0.09B | -71.07% |
| 2021-03-31 | $0.11B | $-0.07B | -64.04% |
| 2020-12-31 | $0.11B | $-0.06B | -56.48% |
| 2020-09-30 | $0.10B | $-0.05B | -51.49% |
| 2020-06-30 | $0.10B | $-0.05B | -50.53% |
| 2020-03-31 | $0.09B | $-0.05B | -49.45% |
| 2019-12-31 | $0.09B | $-0.04B | -45.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.454B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $44.502B | 54.47 |
| Doximity (DOCS) | United States | $12.809B | 56.99 |
| Tempus AI (TEM) | United States | $12.797B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $9.972B | 81.70 |
| IRhythm Technologies (IRTC) | United States | $5.509B | 0.00 |
| Hinge Health (HNGE) | United States | $4.528B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.705B | 39.76 |
| Privia Health (PRVA) | United States | $2.677B | 198.27 |
| Heartflow (HTFL) | $2.609B | 0.00 | |
| Phreesia (PHR) | United States | $1.937B | 0.00 |
| 10x Genomics (TXG) | United States | $1.778B | 0.00 |
| Enovis (ENOV) | United States | $1.749B | 9.24 |
| Omnicell (OMCL) | United States | $1.529B | 29.45 |
| Azenta (AZTA) | United States | $1.372B | 59.84 |
| Clover Health Investments (CLOV) | United States | $1.348B | 0.00 |
| Claritev (CTEV) | United States | $1.174B | 0.00 |
| Evolent Health (EVH) | United States | $1.133B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.674B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.550B | 0.00 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Standard BioTools (LAB) | United States | $0.493B | 0.00 |
| Talkspace (TALK) | United States | $0.445B | 133.00 |
| Butterfly Network (BFLY) | United States | $0.410B | 0.00 |
| Carlsmed (CARL) | United States | $0.363B | 0.00 |
| TruBridge (TBRG) | United States | $0.300B | 52.60 |
| Health Catalyst (HCAT) | United States | $0.257B | 0.00 |
| Outset Medical (OM) | United States | $0.247B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.224B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| CapsoVision (CV) | United States | $0.184B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.164B | 0.00 |
| CareCloud (CCLD) | United States | $0.160B | 7.27 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.115B | 0.00 |
| American Well (AMWL) | United States | $0.113B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.082B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.072B | 0.00 |
| Pulmonx (LUNG) | United States | $0.072B | 0.00 |
| 111 (YI) | China | $0.061B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.044B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Precipio (PRPO) | United States | $0.025B | 0.00 |
| PROFUSA (PFSA) | United States | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.014B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |